Patent details

EP3737750 Title: ALKALINE PHOSPHATASE AGENTS FOR TREATMENT OF NEURODEVELOPMENTAL DISORDERS

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP3737750
WO Application Number:
US2019012671
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP19739158.4
WO Publication Number:
WO2019139891
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:

Dates

Filing date:
08/01/2019
Grant date:
05/06/2024
EP Publication Date:
18/11/2020
WO Publication Date:
18/07/2019
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
05/06/2024
EP B1 Publication Date:
05/06/2024
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
07/01/2039
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
05/06/2024
 
 

 

Name:
Theriva Biologics, Inc.
Address:
9605 Medical Center Drive Suite 270, Rockville, MD 20850, United States of America (US)

Inventor

1

Name:
KALEKO, Michael
Address:
Rockville, MD 20850, United States of America (US)

2

Name:
FURLAN FREGUIA, Christian
Address:
Rockville, MD 20850, United States of America (US)

3

Name:
CONNELLY, Sheila
Address:
Rockville, MD 20850, United States of America (US)

Priority

1

Priority Patent Number:
201862679310 P
Priority Date:
01/06/2018
Priority Country:
United States of America (US)

2

Priority Patent Number:
201862615227 P
Priority Date:
09/01/2018
Priority Country:
United States of America (US)

Classification

IPC or IDT classification:
C12N 9/16; C12Q 1/42; G01N 33/68; A23L 29/00; A61K 35/741; A61P 25/18; A61K 38/46;

Publication

Bulletin

Bulletin Heading:
EP2
Journal edition number:
23/24
Publication date:
05/06/2024
Description:
European patents granted for the Netherlands

European Patent Bulletin

Issue number:
202423
Publication date:
05/06/2024
Description:
Grant (B1)

Annual Fee

Annual Fee(s) Due Date:
31/01/2025
Annual Fee Number:
7
Annual Fee Amount:
220 Euro
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Document Description Number of pages File Type